Bubendorf, Switzerland, June 2016 — CIS Pharma has developed a novel multipurpose solution for contact lenses. With over 25 years of experience and a track record of several lens care products licensed to and sold by partners globally, the team has developed the next generation contact lens care solution that increases contact lens wear comfort while keeping the efficacy of the product. The formulation combines unsurpassed high concentrations of hyaluronic acid without effecting the disinfection potential of the products. The products increase the wear comfort and support the health of the eye. In addition, they are highly effective against harmful bacteria, fungi and acanthamoeba. Long-term stability studies are currently being performed.